.

The process might take six months and the final assessment on the safety and the anti-bodies produced would be made by the safety board.

Three volunteers were administered ” Covaxin”, the corona vaccine of Bharat Biotech, at Post-Graduate Institute (PGI) of Medical Sciences in Rohtak on Friday, as part of the very first stage of clinical trial on the human beings. All 3 tolerated it well with no initial adverse results.

Likewise checked out: DCGI nod for India-made COVID-19 vaccine ‘Covaxin’ human trials

Senior Teacher and Head, department of Pulmonary & Crucial Care Medication, Dhruva Chaudhry, also the co-principal private investigator, informed The Hindu over phone that the three volunteers were short-listed out of the overall 8 after health checks to guarantee appropriate liver function and absence of infection and were